Home ›
Organizations ›
US THROMBOTIC MICROANGIOPATHY ALLIANCE
US THROMBOTIC MICROANGIOPATHY ALLIANCE
OH · Disease Research · EIN 831768842
1
Executives Disclosed
$595K
Annual Revenue
$1.8M
Total Assets
US THROMBOTIC MICROANGIOPATHY ALLIANCE has 1 executive with disclosed compensation. The highest-paid executive, Clare Martin (OPERATIONS D), received peak total compensation of $136,772. The sector average for Disease Research executives is $215K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Clare Martin | OPERATIONS D | $137K | $0 | 2022–2024 | 1.8x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2022 | 1 | $0 | $0 | $0 |
| 2023 | 1 | $0 | $0 | $0 |
| 2024 | 1 | $0 | $0 | $0 |
Email Alerts
Get notified about US THROMBOTIC MICROANGIOPATHY ALLIANCE
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.